Groundbreaking Clinical Trial Shows Safety and Molecular Insights of Pre- and Post-Surgery Immunotherapy Combo in Operable Mesothelioma Patients
In a pioneering advancement that could reshape the therapeutic landscape for operable mesothelioma, researchers at the Johns Hopkins Kimmel Cancer ...
